Atria Investments’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-8,873
| Closed | -$1.39M | – | 757 |
|
|
2020
Q4 | $1.39M | Buy |
8,873
+82
| +0.9% | +$12.8K | 0.03% | 548 |
|
|
2020
Q3 | $1.01M | Buy |
+8,791
| New | +$1.01M | 0.03% | 576 |
|
|
2020
Q2 | – | Sell |
-6,174
| Closed | -$554K | – | 806 |
|
|
2020
Q1 | $554K | Buy |
6,174
+490
| +9% | +$44K | 0.04% | 331 |
|
|
2019
Q4 | $615K | Buy |
5,684
+2,909
| +105% | +$315K | 0.02% | 707 |
|
|
2019
Q3 | $272K | Sell |
2,775
-1,536
| -36% | -$151K | 0.01% | 749 |
|
|
2019
Q2 | $470K | Buy |
4,311
+2,114
| +96% | +$230K | 0.02% | 603 |
|
|
2019
Q1 | $297K | Sell |
2,197
-154
| -7% | -$20.8K | 0.01% | 708 |
|
|
2018
Q4 | $229K | Sell |
2,351
-503
| -18% | -$49K | 0.01% | 764 |
|
|
2018
Q3 | $397K | Buy |
2,854
+122
| +4% | +$17K | 0.02% | 671 |
|
|
2018
Q2 | $339K | Buy |
2,732
+488
| +22% | +$60.6K | 0.01% | 699 |
|
|
2018
Q1 | $250K | Buy |
2,244
+98
| +5% | +$10.9K | 0.01% | 735 |
|
|
2017
Q4 | $257K | Buy |
2,146
+324
| +18% | +$38.8K | 0.01% | 706 |
|
|
2017
Q3 | $256K | Buy |
+1,822
| New | +$256K | 0.01% | 658 |
|
|
2017
Q2 | – | Sell |
-2,456
| Closed | -$298K | – | 801 |
|
|
2017
Q1 | $298K | Sell |
2,456
-224
| -8% | -$27.2K | 0.02% | 517 |
|
|
2016
Q4 | $328K | Buy |
2,680
+429
| +19% | +$52.5K | 0.03% | 444 |
|
|
2016
Q3 | $276K | Buy |
+2,251
| New | +$276K | 0.03% | 421 |
|